Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New developments in the area of diabetes therapeutics at Sanwa Kagaku

March 28, 2000

Ontogen describes results of high-throughput screening for PTP1B inhibitors

March 28, 2000

Recent R&D in PTP1B inhibitors discussed by Pharmacia & Upjohn at ACS meeting

March 28, 2000

Kotobuki's new hypouricemic agent KT-651 inhibits biosynthesis, enhances excretion of uric acid

March 27, 2000

New ACAT inhibitors in development at Sumitomo

March 24, 2000

Takeda's new benzothiepin derivatives enhance bone formation

March 23, 2000

Ligand moves LGD-2226 towards human studies

March 23, 2000

Comparative studies with Hoe-901 and other insulins reported at ASCPT

March 22, 2000

Magainin A: rabbit studies suggest its promise as a vaginal contraceptive

March 22, 2000

Warner-Lambert discontinues sale of Rezulin

March 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...